525
Participants
Start Date
October 31, 2008
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
alb-interferon alfa 2b
900 mcg every 4 weeks
alb-interferon alfa 2b
1200 mcg every 4 weeks
alb-interferon alfa 2b
1500 mcg every 4 weeks
alb-interferon alfa 2b
1800 mcg every 4 weeks
peg-interferon
Peg-interferon alfa 2a: 180 mcg 1x per wk.
Novartis Investigative site, Clayton
Novartis Investigative site, Fitzroy
Novartis Investigative site, Greenslopes
Novartis Investigative site, Kingswood
Novartis Investigative site, Melbourne
Novartis Investigative site, Westmead
Novartis Investigative site, Calgary
Novartis Investigative Site, Downsview
Novartis Investigative site, Montreal
Novartis Investigative site, Toronto
Novartis Investigative site, Vancouver
Novartis Investigative Site, Cretail
Novartis Investigative Site, Nice
Novartis Investigative Site, Paris
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Berlin
Novartis Investigative Site, Cologne
Novartis Investigative site, Düsseldorf
Novartis Investigative Site, Essen
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Heraklion
Novartis Investigative Site, Loannina
Novartis Investigative Site, Patra-Rio
Novartis Investigative Site, Piraeurs
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Chandigarh
Novartis Investigative site, Hyderabad
Novartis Investigative Site, Lucknow
Novartis Investigative Site, Ludhiana
Novartis Investigative Site, Mumbai
Novartis Investigative Site, New Delhi
Novartis Investigative site, Bologna
Novartis Investigative site, Milan
Novartis Investigative site, Napoli
Novartis Investigative site, Pavia
Novartis Investigative site, Pisa
Novartis Investigative site, Polermo
Novartis Investigative site, Torino
Novartis Investigative site, Bialystok
Novartis Investigative site, Lodz
Novartis Investigative site, Barcelona
Novartis Investigative site, Madrid
Novartis Investigative site, Málaga
Novartis Investigative site, Oviedo
Novartis Investigative site, Seville
Novartis Investigative site, Valencia
Novartis Investigative site, Kaohsiung City
Novartis Investigative site, Tainan City
Novartis Investigative site, Taipei
Novartis Investigative site, Bangkok
Novartis Investigative site, Chaingmai
Novartis Investigative Site, Hat Yai
Novartis Investigative Site, Muang
Novartis Investigative Site, Glasgow
Lead Sponsor
Collaborators (1)
Human Genome Sciences Inc.
INDUSTRY
Novartis
INDUSTRY